Pfizer, Astellas prostrate cancer drug clears late-stage trial

Sept 14 (Reuters) - Pfizer Inc and Astellas Pharma Inc said on Thursday their drug to treat a type of prostrate cancer met the main goal of improving overall survival in a late-stage trial.

Positive 0 LOL 0 Interesting 0 Sad 0 Revolting 0 Fake 0

See also

Whoops, looks like something went wrong.